Minimally Invasive, Non Invasive Device Market devices was USD 48.50 Billion in 2022, and it is estimated to grow at a CAGR of 13.4% from 2023 to 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by regionTo know about the Research Methodology :- Request Free Sample Report Minimally Invasive and Non-invasive surgery procedures are those which do not break into the skin of the patients to a great extent. There is no contact with the mucous membrane or internal body cavity or else through a natural or artificial body orifice in case of non-invasive surgeries. Devices are used to evaluate health and detect the presence of a disease in the way similar to taking a pulse or listening to the sounds of the heart and lungs for computing blood pressure or other symptoms. Increasing demand for minimally-invasive/non-invasive heart surgery among patients as these are less time consuming and safer than the normal invasive techniques. Following the rising levels of beauty-consciousness, the market is also witnessing a rising demand especially among cosmetic surgeries forming a key driver for the overall Global Minimally Invasive, Non Invasive Device Market growth. Global Minimally Invasive, Non Invasive Device Market is segmented by geography, products, applications, region, and end-users. Global Minimally Invasive, Non Invasive Device Market devices have predominant usage in hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. Handheld instruments hold the highest market share in 2017 and is expected to grow at one of the highest growth rate during the forecast period. This is attributed to the wide use of handheld instruments in minimally invasive surgical procedures further witnessing a similar trend in foreseeable future. On the basis of geography, North America is expected to dominate the market that can be as a result of higher investments in the healthcare infrastructure and government policies for boosting the healthcare sector. The major players in the Global Minimally Invasive, Non Invasive Device Market are CONMED Corporation, Johnson & Johnson Services Inc, Intuitive Surgical, Medtronic, BOSTON SCIENTIFIC CORPORATION, Abbott, Clarus Medical LLC., The Cooper Companies Inc, KARL STORZ GmbH & Co. KG, Fujifilm Holdings Corporation, and C. R. Bard, Inc. among others. The objective of the report is to present comprehensive Global Minimally Invasive Non Invasive Device Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Minimally Invasive Non Invasive Device Market North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Minimally Invasive Non Invasive Device Market North America for Asia Pacific size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Minimally Invasive Non Invasive Device Market North America for Asia Pacific make the report investor’s guide.
The years that have been considered for the study are:
• Base year – 2022 • Estimated year – 2022 • Forecast period – 2023 to 2029Minimally Invasive and Non Invasive Device Market Market Drivers and Restraints:
• Rising in geriatric population which demands surgeries • Technological advancement in the MIS products • Less pain and rapid recovery • Less healthcare cost • Better surgical results • Increased awareness about MIS procedures • Limited numbers of surgeries are performed with MIS procedures • Lack of skilled healthcare professionals.Minimally Invasive and Non Invasive Device Market Key Highlights:
• Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2017 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities. • Global Minimally Invasive, Non Invasive Device Market analysis, and comprehensive segmentation with respect to the Product, Technology, Application, and geography to assist in strategic business planning. • Global Minimally Invasive, Non Invasive Device Market analysis, and forecast for five major geographies, North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions.Minimally Invasive and Non Invasive Device Market Research Methodology:
The market is estimated by analyzing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of the market were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this analysis. This country-specific analysis was accumulated to establish regional numbers and then arrive at the global market value for Global Minimally Invasive, Non Invasive Device Market.Minimally Invasive and Non Invasive Device Market Key target audience:
• Research and Consulting Firms as well as Venture capitalists, private equity firms, and start-up companies • Market leading companies • Product distributors • Raw material suppliers • Buyers • Government and regulatory authorities Research report categorizes the Global Minimally Invasive and Non Invasive Product and Service Market based on Product, Technology, Application and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Minimally Invasive and Non Invasive Device Market with key developments in companies and market trends.Scope of the Global Minimally Invasive and Non Invasive Device Market: Inquire before buying
Global Minimally Invasive and Non Invasive Device Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 48.50 Bn. Forecast Period 2023 to 2029 CAGR: 13.4% Market Size in 2029: US $ 116.96 Bn. Segments Covered: by Product • Surgical Devices • Monitoring and Visualization System • Endosurgical Equipment • Medical Robotics • Electrosurgical Equipment by Application • Neurosurgery • Cosmetic Surgery • Urology • Obstetrics & Gynaecology • Ophthalmology • Cardiovascular • Orthopaedic Surgery • Laparoscopy • Others (ENT/Respiratory, Dental, and Pediatric Surgeries) by End User • Hospitals • Ambulatory Surgical Clinics • Research Institutes Minimally Invasive and Non Invasive Device Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Minimally Invasive and Non Invasive Device Market Key Players are:
• CONMED Corporation • Johnson & Johnson Services Inc. • Intuitive Surgical • Medtronic • BOSTON SCIENTIFIC CORPORATION • Abbott • Clarus Medical LLC. • The Cooper Companies Inc. • KARL STORZ GmbH & Co. KG • Fujifilm Holdings Corporation • C. R. Bard, Inc. • Zimmer Biomet • K2M, Inc. • Surgical Innovations • HOYA GROUP • Teleflex Incorporated • Stryker • Smith & Nephew plc • NuVasive, Inc. • Olympus Corporation • Mentice AB • Integra LifeSciences Corporation • Auris Surgical Robotics • Alphatec Spine, Inc. • Koninklijke Philips N.V. Frequently Asked questions 1. What is the market size of the Global Minimally Invasive and Non Invasive Device Market in 2022? Ans. The market size Global Minimally Invasive and Non Invasive Device Market in 2022 was US$ 48.50 Billion. 2. What are the different segments of the Global Minimally Invasive and Non Invasive Device Market ? Ans. The Global Minimally Invasive and Non Invasive Device Market is divided into Product, Application and End User. 3. What is the study period of this market? Ans. The Global Minimally Invasive and Non Invasive Device Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Minimally Invasive and Non Invasive Device Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Minimally Invasive and Non Invasive Device Market ? Ans. The Forecast Period of the market is 2023-2029 in the market.
1. INTRODUCTION 1.1. Market description & Scope (2023-2029) 1.2. Objectives 1.2.1. Key Takeaways 1.2.2. Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1. Methods used for market forecasting 2.2. Data Sources 2.2.1. Paid Databases 2.2.2. Primary Sources 2.2.3. Secondary Sources 3. EXECUTIVE SUMMARY 3.1. Major Findings 3.1.1. Key Segment Trends 3.1.1.1. Product 3.1.1.2. Application 3.1.1.3. End-User 3.1.2. Key Regional Trends 3.1.2.1. North America 3.1.2.2. Europe 3.1.2.3. Asia Pacific 3.1.2.4. LAMEA 3.2. Key Companies and their Strategies 4. MARKET OVERVIEW 4.1. Minimally Invasive and Non Invasive Device Concept & Definition 4.2. Segments Overview 4.2.1. By Product 4.2.1.1. Surgical Devices 4.2.1.2. Monitoring and Visualization System 4.2.1.3. Endosurgical Equipment 4.2.1.4. Medical Robotics 4.2.1.5. Electrosurgical Equipment 4.2.2. By Application 4.2.2.1. Neurosurgery 4.2.2.2. Cosmetic Surgery 4.2.2.3. Urology 4.2.2.4. Obstetrics & Gynaecology 4.2.2.5. Ophthalmology 4.2.2.6. Cardiovascular 4.2.2.7. Orthopaedic Surgery 4.2.2.8. Laparoscopy 4.2.2.9. Others 4.2.3. By End-user 4.2.3.1. Hospitals 4.2.3.2. Ambulatory Surgical Clinics 4.2.3.3. Research Institutes 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Porter’s Analysis 4.5. PESTLE Analysis 4.6. Fragmentation 4.6.1. Key strategic Alliances of companies (inorganic & organic) 4.6.2. Company Market Share (Top 10 Players) 4.6.3. Comparative Analysis of Key players in Minimally Invasive and Non Invasive Device 4.7. Key Trends 4.8. Key trends in global Minimally Invasive, Non Invasive Device market 5. GLOBAL MINIMALLY INVASIVE AND NON INVASIVE DEVICE PRODUCT ESTIMATES & TREND ANALYSIS ( 2023-2029) 5.1. Global Minimally Invasive and Non Invasive Device Market: Product Analysis 5.1.1. Surgical Devices 5.1.1.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 5.1.2. Monitoring and Visualization System 5.1.2.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 5.1.3. Endosurgical Equipment 5.1.3.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 5.1.4. Medical Robotics 5.1.4.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 5.1.5. Electrosurgical Equipment 5.1.5.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 5.2. Global Minimally Invasive and Non Invasive Device Market: Product Trends 6. GLOBAL MINIMALLY INVASIVE AND NON INVASIVE DEVICE APPLICATION ESTIMATES & TREND ANALYSIS ( 2023-2029) 6.1. Global Minimally Invasive and Non Invasive Device Market: Application Analysis 6.1.1. Neurosurgery 6.1.1.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.2. Cosmetic Surgery 6.1.2.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.3. Urology 6.1.3.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.4. Obstetrics & Gynaecology 6.1.4.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.5. Ophthalmology 6.1.5.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.6. Cardiovascular 6.1.6.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.7. Orthopaedic Surgery 6.1.7.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.8. Laparoscopy 6.1.8.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.1.9. Others 6.1.9.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 6.2. Global Minimally Invasive and Non Invasive Device Market: Application Trends 7. GLOBAL MINIMALLY INVASIVE AND NON INVASIVE DEVICE END-USER ESTIMATES & TREND ANALYSIS ( 2023-2029) 7.1. Global Minimally Invasive and Non Invasive Device Market: End-User Analysis 7.1.1. Hospitals 7.1.1.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 7.1.2. Ambulatory Surgical Clinics 7.1.2.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 7.1.3. Research Institutes 7.1.3.1. Market Share and growth forecasts, 2023-2029 (USD Billion) 7.2. Global Minimally Invasive and Non Invasive Device Market: End-User Trends 8. REGIONAL ESTIMATES & TREND ANALYSIS ( 2023-2029) 8.1. Global Minimally Invasive and Non Invasive Device market share by Region, 2016 & 2025 8.2. North America 8.2.1. North America Minimally Invasive and Non Invasive Device market, Market Share and growth forecasts, 2023-2029 (USD Billion) 8.2.2. Minimally Invasive and Non Invasive Device Drivers For North America Market 8.2.3. Market Share Analysis and Growth Forecast, by Country 8.2.3.1. US 8.2.3.2. Canada 8.2.4. Country-wise GDP Growth Forecast 8.2.5. Minimally Invasive and Non Invasive Device Trends In North America Market 8.3. Europe 8.3.1. Europe Minimally Invasive and Non Invasive Device market, Market Share and growth forecasts, 2023-2029 (USD Billion) 8.3.2. Minimally Invasive and Non Invasive Device Drivers For Europe Market 8.3.3. Market Share Analysis and Growth Forecast, by Country 8.3.3.1. UK 8.3.3.2. Germany 8.3.3.3. France 8.3.3.4. Russia 8.3.3.5. Spain 8.3.3.6. Italy 8.3.3.7. Others 8.3.4. Country-wise GDP Growth Forecast 8.3.5. Minimally Invasive and Non Invasive Device Trends In Europe Market 8.4. Asia Pacific 8.4.1. Asia Pacific Minimally Invasive and Non Invasive Device market, Market Share and growth forecasts, 2023-2029 (USD Billion) 8.4.2. Minimally Invasive and Non Invasive Device Drivers For Asia Pacific Market 8.4.3. Market Share Analysis and Growth Forecast, by Country 8.4.3.1. China 8.4.3.2. Japan 8.4.3.3. India 8.4.3.4. South Korea 8.4.3.5. Australia 8.4.3.6. Others 8.4.4. Country-wise GDP Growth Forecast 8.4.5. Minimally Invasive and Non Invasive Device Trends In Asia Pacific Market 8.5. LAMEA 8.5.1. LAMEA Minimally Invasive and Non Invasive Device market, Market Share and growth forecasts, 2023-2029 (USD Billion) 8.5.2. Minimally Invasive and Non Invasive Device Drivers For LAMEA Market 8.5.3. Market Share Analysis and Growth Forecast, by Country 8.5.3.1. Middle-east 8.5.3.2. Latin America 8.5.3.3. Africa 8.5.4. Country-wise GDP Growth Forecast 8.5.5. Minimally Invasive and Non Invasive Device Trends In LAMEA Market 9. MARKET SHARE ANALYSIS 9.1. Key Players Regional Market share Analysis 9.1.1. North America 9.1.2. Europe 9.1.3. Asia Pacific 9.1.4. RoW 10. MARKET COMPETITION ANALYSIS 10.1. Strategy Framework 10.2. Consolidation 10.2.1. Patent Analysis 10.2.2. Mergers & Acquisitions 10.2.2.1. Product Based 10.2.2.2. Services Based 10.2.2.3. Region Based 10.2.2.4. List of Mergers & Acquisitions 10.2.3. Company Benchmarking (Revenue & Profit Based) 10.2.4. Strategic Assessment of Company Consolidations 10.2.5. Emerging Business Models 10.3. Company Profiles 10.3.1. CONMED Corporation 10.3.1.1. Company overview 10.3.1.2. Key financials 10.3.1.3. Geographical presence 10.3.1.4. Product and Business Segments 10.3.1.5. Strategic initiatives 10.3.1.6. SWOT analysis 10.3.1.7. Competitive positioning and landscape 10.3.2. Johnson & Johnson Services Inc. 10.3.2.1. Company overview 10.3.2.2. Key financials 10.3.2.3. Geographical presence 10.3.2.4. Product and Business Segments 10.3.2.5. Strategic initiatives 10.3.2.6. SWOT analysis 10.3.2.7. Competitive positioning and landscape 10.3.3. Intuitive Surgical 10.3.3.1. Company overview 10.3.3.2. Key financials 10.3.3.3. Geographical presence 10.3.3.4. Product and Business Segments 10.3.3.5. Strategic initiatives 10.3.3.6. SWOT analysis 10.3.3.7. Competitive positioning and landscape 10.3.4. Medtronic 10.3.4.1. Company overview 10.3.4.2. Key financials 10.3.4.3. Geographical presence 10.3.4.4. Product and Business Segments 10.3.4.5. Strategic initiatives 10.3.4.6. SWOT analysis 10.3.4.7. Competitive positioning and landscape 10.3.5. BOSTON SCIENTIFIC CORPORATION 10.3.5.1. Company overview 10.3.5.2. Key financials 10.3.5.3. Geographical presence 10.3.5.4. Product and Business Segments 10.3.5.5. Strategic initiatives 10.3.5.6. SWOT analysis 10.3.5.7. Competitive positioning and landscape 10.3.6. Abbott 10.3.6.1. Company overview 10.3.6.2. Key financials 10.3.6.3. Geographical presence 10.3.6.4. Product and Business Segments 10.3.6.5. Strategic initiatives 10.3.6.6. SWOT analysis 10.3.6.7. Competitive positioning and landscape 10.3.7. Clarus Medical LLC. 10.3.7.1. Company overview 10.3.7.2. Key financials 10.3.7.3. Geographical presence 10.3.7.4. Product and Business Segments 10.3.7.5. Strategic initiatives 10.3.7.6. SWOT analysis 10.3.7.7. Competitive positioning and landscape 10.3.8. The Cooper Companies Inc. 10.3.8.1. Company overview 10.3.8.2. Key financials 10.3.8.3. Geographical presence 10.3.8.4. Product and Business Segments 10.3.8.5. Strategic initiatives 10.3.8.6. SWOT analysis 10.3.8.7. Competitive positioning and landscape 10.3.9. KARL STORZ GmbH & Co. KG 10.3.9.1. Company overview 10.3.9.2. Key financials 10.3.9.3. Geographical presence 10.3.9.4. Product and Business Segments 10.3.9.5. Strategic initiatives 10.3.9.6. SWOT analysis 10.3.9.7. Competitive positioning and landscape 10.3.10. Fujifilm Holdings Corporation 10.3.10.1. Company overview 10.3.10.2. Key financials 10.3.10.3. Geographical presence 10.3.10.4. Product and Business Segments 10.3.10.5. Strategic initiatives 10.3.10.6. SWOT analysis 10.3.10.7. Competitive positioning and landscape 10.3.11. C. R. Bard, Inc. 10.3.11.1. Company overview 10.3.11.2. Key financials 10.3.11.3. Geographical presence 10.3.11.4. Product and Business Segments 10.3.11.5. Strategic initiatives 10.3.11.6. SWOT analysis 10.3.11.7. Competitive positioning and landscape 10.3.12. Zimmer Biomet 10.3.12.1. Company overview 10.3.12.2. Key financials 10.3.12.3. Geographical presence 10.3.12.4. Product and Business Segments 10.3.12.5. Strategic initiatives 10.3.12.6. SWOT analysis 10.3.12.7. Competitive positioning and landscape 10.3.13. K2M, Inc. 10.3.13.1. Company overview 10.3.13.2. Key financials 10.3.13.3. Geographical presence 10.3.13.4. Product and Business Segments 10.3.13.5. Strategic initiatives 10.3.13.6. SWOT analysis 10.3.13.7. Competitive positioning and landscape 10.3.14. Surgical Innovations 10.3.14.1. Company overview 10.3.14.2. Key financials 10.3.14.3. Geographical presence 10.3.14.4. Product and Business Segments 10.3.14.5. Strategic initiatives 10.3.14.6. SWOT analysis 10.3.14.7. Competitive positioning and landscape 10.3.15. HOYA GROUP 10.3.15.1. Company overview 10.3.15.2. Key financials 10.3.15.3. Geographical presence 10.3.15.4. Product and Business Segments 10.3.15.5. Strategic initiatives 10.3.15.6. SWOT analysis 10.3.15.7. Competitive positioning and landscape 10.3.16. Teleflex Incorporated 10.3.16.1. Company overview 10.3.16.2. Key financials 10.3.16.3. Geographical presence 10.3.16.4. Product and Business Segments 10.3.16.5. Strategic initiatives 10.3.16.6. SWOT analysis 10.3.16.7. Competitive positioning and landscape 10.3.17. Stryker 10.3.17.1. Company overview 10.3.17.2. Key financials 10.3.17.3. Geographical presence 10.3.17.4. Product and Business Segments 10.3.17.5. Strategic initiatives 10.3.17.6. SWOT analysis 10.3.17.7. Competitive positioning and landscape 10.3.18. Smith & Nephew plc 10.3.18.1. Company overview 10.3.18.2. Key financials 10.3.18.3. Geographical presence 10.3.18.4. Product and Business Segments 10.3.18.5. Strategic initiatives 10.3.18.6. SWOT analysis 10.3.18.7. Competitive positioning and landscape 10.3.19. NuVasive, Inc. 10.3.19.1. Company overview 10.3.19.2. Key financials 10.3.19.3. Geographical presence 10.3.19.4. Product and Business Segments 10.3.19.5. Strategic initiatives 10.3.19.6. SWOT analysis 10.3.19.7. Competitive positioning and landscape 10.3.20. Olympus Corporation 10.3.20.1. Company overview 10.3.20.2. Key financials 10.3.20.3. Geographical presence 10.3.20.4. Product and Business Segments 10.3.20.5. Strategic initiatives 10.3.20.6. SWOT analysis 10.3.20.7. Competitive positioning and landscape 10.3.21. Mentice AB 10.3.21.1. Company overview 10.3.21.2. Key financials 10.3.21.3. Geographical presence 10.3.21.4. Product and Business Segments 10.3.21.5. Strategic initiatives 10.3.21.6. SWOT analysis 10.3.21.7. Competitive positioning and landscape 10.3.22. Integra LifeSciences Corporation 10.3.22.1. Company overview 10.3.22.2. Key financials 10.3.22.3. Geographical presence 10.3.22.4. Product and Business Segments 10.3.22.5. Strategic initiatives 10.3.22.6. SWOT analysis 10.3.22.7. Competitive positioning and landscape 10.3.23. Auris Surgical Robotics 10.3.23.1. Company overview 10.3.23.2. Key financials 10.3.23.3. Geographical presence 10.3.23.4. Product and Business Segments 10.3.23.5. Strategic initiatives 10.3.23.6. SWOT analysis 10.3.23.7. Competitive positioning and landscape 10.3.24. Alphatec Spine, Inc. 10.3.24.1. Company overview 10.3.24.2. Key financials 10.3.24.3. Geographical presence 10.3.24.4. Product and Business Segments 10.3.24.5. Strategic initiatives 10.3.24.6. SWOT analysis 10.3.24.7. Competitive positioning and landscape 10.3.25. Koninklijke Philips N.V. 10.3.25.1. Company overview 10.3.25.2. Key financials 10.3.25.3. Geographical presence 10.3.25.4. Product and Business Segments 10.3.25.5. Strategic initiatives 10.3.25.6. SWOT analysis 10.3.25.7. Competitive positioning and landscape